GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » Net Margin %

C4X Discovery Holdings (FRA:C4J) Net Margin % : 72.22% (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. C4X Discovery Holdings's Net Income for the six months ended in Jan. 2024 was €20.76 Mil. C4X Discovery Holdings's Revenue for the six months ended in Jan. 2024 was €28.75 Mil. Therefore, C4X Discovery Holdings's net margin for the quarter that ended in Jan. 2024 was 72.22%.

The historical rank and industry rank for C4X Discovery Holdings's Net Margin % or its related term are showing as below:

FRA:C4J' s Net Margin % Range Over the Past 10 Years
Min: -4742.66   Med: -476.05   Max: 42.81
Current: 42.81


FRA:C4J's Net Margin % is ranked better than
96.68% of 1024 companies
in the Biotechnology industry
Industry Median: -153.97 vs FRA:C4J: 42.81

C4X Discovery Holdings Net Margin % Historical Data

The historical data trend for C4X Discovery Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings Net Margin % Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -68.13 -302.36 -649.80

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,849.37 -138.38 -231.41 -21,062.50 72.22

Competitive Comparison of C4X Discovery Holdings's Net Margin %

For the Biotechnology subindustry, C4X Discovery Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's Net Margin % falls into.



C4X Discovery Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

C4X Discovery Holdings's Net Margin for the fiscal year that ended in Jul. 2023 is calculated as

Net Margin=Net Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-12.944/1.992
=-649.80 %

C4X Discovery Holdings's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=20.761/28.748
=72.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C4X Discovery Holdings  (FRA:C4J) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


C4X Discovery Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines